Loading
A phase 2 trial in colorectal cancer, run by Hebei Medical University Fourth Hospital, now recruiting.
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer is a phase 2, interventional study registered as NCT06949098 by Hebei Medical University Fourth Hospital, with a registry enrolment figure of 60 participants, started 2025-05-15 and due to reach its primary completion in 2032-03. Interventions recorded: Local Tumor Resection; Radiotherapy; Chemotherapy. Conditions listed: Rectal Cancer Stage I. Primary outcome: 5-year DFS Rate. Colorectal eligibility wording from the registry: "Biopsy-proven rectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.